AllianceBernstein’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $10.6M | Buy |
|
|||||
|
2024
Q3 | $16.9M | Buy |
|
|||||
|
2024
Q2 | $310K | Buy |
|
|||||
|
2024
Q1 | $445K | Sell |
|
|||||
|
2023
Q4 | $800K | Hold |
|
|||||
|
2023
Q3 | $1.04M | Sell |
|
|||||
|
2023
Q2 | $65.7M | Buy |
|
|||||
|
2023
Q1 | $63.7M | Buy |
|
|||||
|
2022
Q4 | $1.56M | Sell |
|
|||||
|
2022
Q3 | $3.14M | Hold |
|
|||||
|
2022
Q2 | $1.61M | Sell |
|
|||||
|
2022
Q1 | $2.81M | Buy |
|
|||||
|
2021
Q4 | $2.35M | Sell |
|
|||||
|
2021
Q3 | $91.4M | Buy |
|
|||||
|
2021
Q2 | $91.5M | Sell |
|
|||||
|
2021
Q1 | $93.7M | Buy |
|
|||||
|
2020
Q4 | $86.9M | Buy |
|
|||||
|
2020
Q3 | $65.5M | Sell |
|
|||||
|
2020
Q2 | $68.2M | Buy |
|
|||||
|
2020
Q1 | $32.7M | Buy |
|
|||||
|
2019
Q4 | $31.7M | Sell |
|
|||||
|
2019
Q3 | $27M | Buy |
|
|||||
|
2019
Q2 | $26.5M | Buy |
|
|||||
|
2019
Q1 | $32.2M | Buy |
|
|||||
|
2018
Q4 | $31.4M | Sell |
|
|||||
|
2018
Q3 | $41.1M | Buy |
|
|||||
|
2018
Q2 | $36M | Buy |
|
|||||
|
2018
Q1 | $35.1M | Buy |
|
|||||
|
2017
Q4 | $32.5M | Buy |
|
|||||
|
2017
Q3 | $601K | Sell |
|
|||||
|
2017
Q2 | $634K | Hold |
|
|||||
|
2017
Q1 | $499K | Sell |
|
|||||
|
2016
Q4 | $575K | Sell |
|
|||||
|
2016
Q3 | $477K | Sell |
|
|||||
|
2016
Q2 | $480K | Buy |
|
|||||
|
2016
Q1 | $442K | Hold |
|
|||||
|
2015
Q4 | $864K | Buy |
|
|||||
|
2015
Q3 | $661K | Buy |
|
|||||
|
2015
Q2 | $636K | Buy |
|
|||||
|
2015
Q1 | $149K | Sell |
|
|||||
|
2014
Q4 | $9.76M | Buy |
|
|||||
|
2014
Q3 | $9.97M | Buy |
|
|||||
|
2014
Q2 | $12.7M | Buy |
|